Cubicin & Product use in unapproved indication

12.1%

of users reported Product use in unapproved indication

50.0%

also reported Hospitalization

51.3%

are women

Hospitalization

50.0%

Severe reaction

46.9%

Life-threatening condition

3.1%

Cubicin: general information

10 - 19 years

0.5%

20 - 29 years

2.3%

30 - 39 years

4.5%

40 - 49 years

9.4%

50 - 59 years

17.3%

60 - 69 years

28.8%

70 - 79 years

25.3%

80 - 89 years

11.9%